CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - 9 months ended Mar. 31, 2017 - USD ($)	Series A convertible preferred stock Preferred Stock	Series B convertible preferred stock Preferred Stock	Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Jun. 30, 2016	$ 12,500,000	$ 1,200,000	$ 3,224	$ 32,226,851	$ (44,612,495)	$ 1,317,580
Balance (in shares) at Jun. 30, 2016	1,250,000	120,000	32,231,241
Increase (Decrease) in Stockholders' Equity
Issuance of common stock, net			$ 639	13,562,519		13,563,158
Issuance of common stock, net (in shares)			6,441,879
Conversion of preferred stock to common stock	$ (11,459,872)	$ (1,200,000)	$ 2,495	12,657,377
Conversion of preferred stock to common stock (in shares)	(1,145,987)	(120,000)	24,946,162
Stock based compensation expense			$ 5	1,483,151		1,483,156
Exercise of warrants			$ 5	160,412		160,417
Exercise of warrants (in shares)			50,000
Exercise of stock options			$ 3	31,274		31,277
Exercise of stock options (in shares)			38,066
Net loss					(16,941,010)	(16,941,010)
Balance at Mar. 31, 2017	$ 1,040,128		$ 6,371	$ 60,121,584	$ (61,553,505)	$ (385,422)
Balance (in shares) at Mar. 31, 2017	104,013		63,707,348